News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Monday, March 16, 2026The European Commissions Health Package introduces the EU Biotech Act with SPC extensions and faster approvals to enhance biopharma competitiveness
JPMorgan Identifies Top EU Pharma, Biotech & Life Sciences Stocks Poised for 2026 Growth
Friday, March 13, 2026JPMorgan forecasts significant growth for leading European pharma biotech and life sciences companies in highlighting AstraZeneca Novartis and Bayer among top performers
Aminex Therapeutics receives second FDA orphan drug designation for AMXT 1501 targeting malignant glioma including DIPG
Friday, March 13, 2026Aminex Therapeutics Inc a clinicalstage biotechnology company developing metabolictargeted cancer therapies has received Orphan Drug Designation from the US Food and Drug Administration for AMXT
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Thursday, March 12, 2026The European Commissions Health Package progresses with the EU Biotech Act offering SPC extensions for biotechs and faster clinical trial approvals to enhance life sciences competitiveness
Catalent and GelMEDIX form global partnership to advance iPSC-derived cell therapies for ocular and retinal diseases
Thursday, March 12, 2026GelMEDIX and Catalent have entered a global partnership to support the development and clinical manufacturing of induced pluripotent stem cell iPSCderived therapies aimed at treating ocular and retinal diseases
Curatis and Neupharma Sign Exclusive Licensing Deal to Develop Corticorelin for Brain Oedema Treatment in Japan
Wednesday, March 11, 2026Curatis Holding AG and Neupharma Co Ltd have signed an exclusive licensing and development agreement for corticorelin CPTBE in Japan
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Wednesday, March 11, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
NewcelX collaborates with Eledon Pharmaceuticals to advance NCEL-101 programme for Type 1 diabetes
Tuesday, March 10, 2026NewcelX Ltd has announced a research collaboration with Eledon Pharmaceuticals Inc to support the development of its NCEL programme for the treatment of Type diabetes
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Tuesday, March 10, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Monday, March 09, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
